source
- Kelun-Biotech reports first-line success of Merck-partnered ADC sacituzumab tirumotecan in ChinaKelun-Biotech announced that its antibody‑drug conjugate sacituzumab tirumotecan, developed in partnership with Merck, achieved its primary efficacy endpoints when used as a first‑line therapy in a…
- Uganda remains silent on Marburg outbreak updates, WHO saysThe World Health Organization noted that Uganda has not provided any new information since it announced a Marburg virus outbreak late last month. WHO officials have sent multiple requests for deta…